Teva's acquired product is currently undergoing review by the FDA.
1 report, 1 independent
Updated Aug 28
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Teva's acquired product is currently undergoing review by the FDA.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Teva Pharmaceutical Industries Ltd.
Israeli pharmaceutical company
Related events
- Teva Pharmaceutical Industries Ltd. submitted an NDA for ecopipam to the FDA.
- Leerink partners issued an 'outperform' rating on Teva stock, while an insider sold shares of the company.
- Teva Pharmaceutical Industries discussed company strategy at an event hosted by Morgan Stanley.
- Merck is seeking FDA approval for its drug Winrevair, based on data from the ZENITH, HYPERION, and Stellar studies.
- BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.